首页> 外文期刊>Indian journal of surgical oncology >Bilateral Risk-Reducing Prophylactic Mastectomies in an Unaffected BRCA1 Carrier Using Dermal Sling and Implant
【24h】

Bilateral Risk-Reducing Prophylactic Mastectomies in an Unaffected BRCA1 Carrier Using Dermal Sling and Implant

机译:使用皮肤吊带和植入物在不受影响的BRCA1载体中减少双侧风险的预防性乳腺切除术

获取原文
       

摘要

Hereditary breast cancer (HBC) accounts for 5–10% of all breast cancer patients. Mutations in BRCA 1 and 2 are the most common culprits of HBC. These patients have a much higher lifetime risk of developing breast cancer than the non-carriers. Thus these high-risk patients qualify to receive risk-reducing measures in form of close surveillance, chemoprophylaxis, or sometimes even risk-reducing surgeries in high penetrance mutation carriers. We report a case of bilateral risk-reducing prophylactic mastectomies (B/L RRM) and bilateral risk-reducing salpingo-oophorectomy (B/L RRSO) performed in a 37-year-old healthy BRCA 1 carrier. Although, this is an age-old practice, its acceptance in India has been low for reasons such as cost of surgery, social stigma, lack of awareness, fear of visiting an oncology clinic, surgery and reconstruction, or loss of a healthy organ; and more acceptance towards other risk reduction methods.
机译:遗传性乳腺癌(HBC)占所有乳腺癌患者的5-10%。 BRCA 1和2中的突变是HBC最常见的罪魁祸首。 这些患者的寿命更高,患有乳腺癌的寿命高于非载体。 因此,这些高风险患者有资格获得高渗透官携带者的密切监测,化学抑制,或有时甚至有时候降低风险降低的患者的风险降低措施。 我们举报了在37岁的健康BRCA 1载体中进行了双侧风险降低预防性粪便切除术(B / L RRM)和双侧风险降低的降温术 - 诺柯仑切除术(B / L RRSO)。 虽然这是一个古老的实践,但它在印度的验收是出于手术成本,社会耻辱,意识的成本等原因较低,担心访问肿瘤诊所,手术和重建,或丧失健康器官; 并对其他风险减少方法的接受程度更多。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号